Chaga Mushroom Fungus Sclerotium Extract 40% Polysaccharides 30% Beta Glucan ~8:1 (Inonotus obliquus) - ExportF
NIGEHER009776
Chaga Mushroom Fungus Sclerotium Extract is derived from the sclerotium of the Inonotus obliquus fungus. This technical-grade raw material is manufactured to a standardized extract ratio of approximately 8:1. The specification dictates a minimum constituent profile containing 40% polysaccharides and 30% beta glucan, ensuring a precise concentration of these key fungal compounds in each production batch.
Supplied as a dry powder, this ingredient exhibits technical properties suitable for solid-dosage manufacturing and encapsulation processes. Due to its classification, application is restricted to nutritional supplements, where it integrates cleanly into multi-ingredient formulas, tablets, and hard-shell capsules. The powder is processed to preserve its specification parameters, delivering consistent dispersibility and uniform blending characteristics during commercial compounding.
🍃This material is supplied business-to-business as a raw material for use in manufacturing. It is not sold to consumers and is not intended for direct consumption. No health claims are made for this ingredient. Information is provided in good faith for technical and formulation purposes; the current Technical Data Sheet and Certificate of Analysis take precedence. Responsibility for confirming the regulatory status of this material, and for the compliance, labelling and claims of any finished product, rests with the manufacturer. Any errors or omissions? Please let us know.✨🍃
Master Nutraceuticals Product Specification:
Loading documents…
Connect with our sales team

Connect with one of the world’s leading nutraceutical specialists. Speak directly with our NPD and supply chain experts to source ingredients or formulate bespoke custom blends.
Thank you! Your inquiry has been sent to our global sales team.